Department of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey.
Department of Nutrition and Dietetics, Hacettepe University Faculty of Health Sciences, Ankara, Turkey.
Appetite. 2022 Jan 1;168:105776. doi: 10.1016/j.appet.2021.105776. Epub 2021 Oct 26.
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age that is associated with eating disorders and disordered eating. No data is available regarding taste function in women with PCOS. The aim of this study was to assess taste function and eating behavior in patients with PCOS compared to healthy women and investigate potential impact of oral contraceptive (OC) use on those. Forty-four patients with PCOS and 36 age and body-mass-index matched healthy controls were enrolled. Gustatory function was assessed by taste strips (sweet, sour, salty, bitter) and Food Cravings Questionnaire-Trait (FCQ-T), Night Eating Questionnaire (NEQ) and Three Factor Eating Questionnaire-R18 (TFEQ-R18) were applied. All measurements were repeated in patients after receiving an OC along with general lifestyle advice for 3 months. At baseline, PCOS group had lower total taste strip test (TST) scores compared to controls (11.7 ± 2.2 vs. 13.1 ± 1.4; p = 0.001). Subgroup analysis showed lower sour and salty taste scores in PCOS group (2.4 ± 0.9 vs. 2.9 ± 0.7; p = 0.004; and 2.6 ± 1 vs. 3.1 ± 0.7; p = 0.01 respectively). Sweet and bitter taste scores were similar. No difference was determined in eating behavior. Linear regression analysis revealed that hyperandrogenism was significant predictor for total TST score (R = 0.22, p < 0.001). Higher free androgen index (FAI) was associated with lower total TST score (p = 0.01). Total TST score, TFEQ-R18 and NEQ scores remained unaltered after treatment in the PCOS group whereas FCQ-T scores showed significant reduction (p = 0.02), mainly due to a decrease in lack of control subscale (p = 0.01). Our results suggest that taste perception is reduced in PCOS, and short-term OC use does not alter taste functions in the syndrome.
多囊卵巢综合征(PCOS)是育龄妇女最常见的内分泌疾病之一,与饮食障碍和饮食失调有关。目前尚无关于 PCOS 患者味觉功能的相关数据。本研究旨在评估 PCOS 患者与健康女性的味觉功能和饮食行为,并探讨口服避孕药(OC)使用对这些功能的潜在影响。研究纳入了 44 名 PCOS 患者和 36 名年龄和体重指数匹配的健康对照组。使用味觉条(甜、酸、咸、苦)和食物渴求问卷特质分量表(FCQ-T)、夜间饮食问卷(NEQ)和三因素饮食问卷-R18(TFEQ-R18)评估味觉功能。所有测量值均在患者接受 OC 并接受 3 个月的一般生活方式建议后重复。基线时,PCOS 组的总味觉条测试(TST)评分低于对照组(11.7±2.2 对 13.1±1.4;p=0.001)。亚组分析显示,PCOS 组的酸味和咸味味觉评分较低(2.4±0.9 对 2.9±0.7;p=0.004;2.6±1 对 3.1±0.7;p=0.01),甜味和苦味味觉评分相似。饮食行为无差异。线性回归分析显示,高雄激素血症是 TST 总评分的显著预测因素(R=0.22,p<0.001)。较高的游离雄激素指数(FAI)与较低的 TST 总评分相关(p=0.01)。PCOS 组治疗后 TST 总评分、TFEQ-R18 和 NEQ 评分无变化,而 FCQ-T 评分显著降低(p=0.02),主要归因于控制不足亚量表的降低(p=0.01)。我们的结果表明,PCOS 患者的味觉感知能力降低,短期 OC 使用不会改变该综合征的味觉功能。